Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 800-253-4 | CAS number: 1419212-73-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
Skin irritation/corrosion
In EPISKIN model (Harlan 2013), reconstructed human skin tissues in triplicate were treated with 30 uL of the test substance during 15 minutes. Optical density of extracted MTT solutions was measured at 540 nm. Viability was expressed as the corrected percentage MTT conversion versus negative control. The viability was 109.2%, which is indicative for non-irritant substances. The test substance is non-irritant in the EPISKIN reconstructed human epidermal model. In the EpiSKIN test (Harlan 2014), duplicate tissues of reconstructed human skin were treated with 50 uL of the test substance during 3, 60 and 240 minutes. After treatment tissues were rinsed and incubated with MTT for 3 hours (at room temperature). Optical density of homogene solutions of MTT treated tissues was measured at 540 nm. As the test substance was shown to interfere with the MTT reduction, additional controls were included (non-viable tissue). The true viability was 74.7 -94.2% for the different exposure times, which is indicative for non-corrosive substances.
Eye irritation
In the SkinEthic assay (Harlan 2014) SkinEthic tissues were treated with 30 uL of the test substance in triplicate during 10 minutes. After treatment tissues (2 per treatment) were rinsed and treated with MTT. Optical density of extracted MTT solutions was measured at 540 nm. As the test substance interfered with MTT reduction to formazan, viability was expressed as percentage MTT conversion versus negative control with a correction for true viability (0.252). The true viability was 57.2%, which is indicative for irritant substances. As the assay is not formally validated, the results need to be regarded as preliminary, but worst case. In an in vivo study (Harlan 2015) the substance was installed in the eye of 2 rabbits (subsequently treated). The results are indicative for the classification as irritating to the eyes
Key value for chemical safety assessment
Skin irritation / corrosion
Link to relevant study records
- Endpoint:
- skin corrosion: in vitro / ex vivo
- Remarks:
- in vitro
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 06-10-2012 to 09-10-2012
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: study performed according to the guideline and under GLP
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 431 (In Vitro Skin Corrosion: Human Skin Model Test)
- Qualifier:
- according to guideline
- Guideline:
- other: EU B40bis (EC440/2008)
- GLP compliance:
- yes (incl. QA statement)
- Details on study design:
- The EpiSKIN assay uses reconstructed human epidermis to assess skin corrosion. For the viability test enzymatic conversion of MTT to formazan is used.
In a pre-test direct interaction of the test substance with the detection chemical MTT is assessed. As the substance showed interference additional controls were added (water killed EPISKIN tissues). - Irritation / corrosion parameter:
- % tissue viability
- Run / experiment:
- 3 min
- Value:
- 94.2
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Irritation / corrosion parameter:
- % tissue viability
- Run / experiment:
- 60 min
- Value:
- 74.7
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Irritation / corrosion parameter:
- % tissue viability
- Run / experiment:
- 240 min
- Value:
- 84.4
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Other effects / acceptance of results:
- The test substance interfered with the reduction of MTT to blue formazan salt. Direct reduction compared to negative controls was 6.1 to 29.1% (validity criterion < 30%).
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The test substance is non-corrosivein the EPISKIN reconstructed human epidermal model.
- Executive summary:
In the EpiSKIN test, tissues of reconstructed human skin were treated with 50 uL of the test substance in duplicate during 3, 60 and 240 minutes. After treatment tissues were rinsed and incubated with MTT for 3 hours (at room temeprature). Thereafter tissues were allowed to dry, epidermis and collagen were separated, suspended (after vortexing) in isopropanol and kept overnight (all procedures in dark). Optical density of homogene solutions of MTT treated tissues was measured at 540 nm. As the test substance was shown to interfere with the MTT reduction, additional controls were included (non-viable tissue). Viability was expressed as the corrected percentage MTT conversion versus negative control. The true viability was 74.7 -94.2% for the different exposure times, which is indicative for non-corrosive substances.
- Endpoint:
- skin irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 06-02-2013 to 11-02-2013
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: study performed according to the guideline and under GLP
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.46 (In Vitro Skin Irritation: Reconstructed Human Epidermis Model Test)
- Principles of method if other than guideline:
- exposure period 15 minutes with post-exposure incubation period of 42 hours
- GLP compliance:
- yes (incl. QA statement)
- Details on study design:
- The EpiSKIN assay uses reconstructed human epidermis to assess skin irritation. For the viability test enzymatic conversion of MTT to formazan is used.
In a pre-test direct interaction of the test substance with the detection chemical MTT is assessed. As the substance showed interference additional controls were added (water killed EPISKIN tissues).
In the main study triplicate tissues (both viable and killed) were treated with 30 uL of the test substance during 15 minutes. In addition triplicate tissues were treated with a negative control (DPBS) and a positive control (5% SDS) (non-viable tissues were treated with DPBS). After treatment tissues were rinsed, incubated in maintenance fluid for 42 hours at 37 °C and treated with MTT during 3 hours (at 37 °C). After MTT loading a total biopsy of each epidermis (epidermis and collagen) was made, that was suspended in acidified iso-propanol for 3 days and kept in the refrigerator at 1-10°C. Thereafter the optical density of the extracted MTT solutions was measured at 540 nm. Viability was expressed as percentage MTT conversion versus negative control with a correction for true viability according to EpiSkin™ SOP, Version 1.8 (February 2009), ECVAM Skin Irritation Validation Study: Validation of the EpiSkin™ test method 15 min - 42 hours for the prediction of acute skin irritation of chemicals. ( TODTT = [ODTV – (ODkt - ODku)] )
Tissue viability > 50% means non-irritant
Tissue viability ≤ 50% means irritant - Irritation / corrosion parameter:
- % tissue viability
- Value:
- 109.2
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Other effects / acceptance of results:
- The test substance interfered with the reduction of MTT to blue formazan salt (correction factor 0.109).
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The test substance is non-irritant in the EPISKIN reconstructed human epidermal model.
- Executive summary:
In this assay reconstructed human skin tissues were treated with 30 uL of the test substance in triplicate during 15 minutes. After treatment tissues were rinsed, kept for 42 hours and treated with MTT. Optical density of extracted MTT solutions was measured at 540 nm. As the test substance was shown to interfere with the MTT reduction, additional controls were included (non-viable tissue). Viability was expressed as the corrected percentage MTT conversion versus negative control. The viability was 109.2%, which is indicative for non-irritant substances.
The test substance is non-irritant in the EPISKIN reconstructed human epidermal model.
Referenceopen allclose all
Exposure time |
Mean corrected OD540 |
Correction applied |
Relative mean viability |
|
Negative control: |
240 min |
0.772 |
|
100 % |
Positive controls: |
240 min |
0.029 |
|
3.8% |
Test substance |
3 min 60 min 240 min |
0.727* 0.577* 0.655* |
0.046# 0.197# 0.225# |
94.2% 74.7% 84.8% |
* TODTT = [ODTV – (ODkt - ODku)]
# correction value: ODkt - ODku
ODTV : chemical treated viable tissues
TODTT : true MTT metabolic conversion for treated tissue.
ODku : untreated killed tissues
ODkt: chemical treated killed tissues
|
Mean corrected OD540± SD |
Correction applied |
Relative mean viability ± SD |
Negative control: |
0.882 ± 0.056 |
|
100 ± 6.9% |
Test substance: |
0.898 ± 0.055* |
0.109# |
109.2 ± 6.7% |
SDS: |
0.064 ± 0.005 |
|
7.8 ± 0.6% |
* TODTT = [ODTV – (ODkt - ODku)]
# correction value: ODkt - ODku
ODTV : chemical treated viable tissues
TODTT : true MTT metabolic conversion for treated tissue.
ODku : untreated killed tissues
ODkt: chemical treated killed tissues
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Eye irritation
Link to relevant study records
- Endpoint:
- eye irritation: in vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 26-01-2015 to 09-03-2014
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: study according to the guidelines under GLP
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 405 (Acute Eye Irritation / Corrosion)
- GLP compliance:
- yes (incl. QA statement)
- Species:
- rabbit
- Strain:
- New Zealand White
- Details on test animals or tissues and environmental conditions:
- TEST ANIMALS
- Source: Harlan Laboratories UK Ltd., Leicestershire, UK
- Strain: New Zealand White (Hsdlf:NZW)
- Age at study initiation: 12 and 20 weeks
- Weight at study initiation: 2.6 and 3.1 kg
- Housing: individually
- Water: ad libitum
- Feed: 2930C Teklad Global Rabbit diet ad libitum
- Acclimation period: ≥ 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 17-23 °C
- Humidity (%): 30-70%
- Air changes (per hr): ≥ 15/hour
- Photoperiod (hrs dark / hrs light): 12/12 - Vehicle:
- unchanged (no vehicle)
- Controls:
- not required
- Amount / concentration applied:
- TEST MATERIAL: 0.1 mL
- Observation period (in vivo):
- Animal 1 21 days, Animal 2 14 days
Scoring at 1, 24, 46 and 72 h and 7, 14 and 21 days after instillation - Number of animals or in vitro replicates:
- 2
- Details on study design:
- REMOVAL OF TEST SUBSTANCE
- Washing (if done): none
SCORING SYSTEM: Draize with calculations of irritation score according to modified version of the system described by Kay J.H. and Calandra J.C. (1962))
TOOL USED TO ASSESS SCORE: light of ophthalmoscope - Irritation parameter:
- cornea opacity score
- Basis:
- animal #1
- Time point:
- 24/48/72 h
- Score:
- 1
- Max. score:
- 1
- Reversibility:
- fully reversible within: 21 days
- Irritation parameter:
- iris score
- Basis:
- animal #1
- Time point:
- 24/48/72 h
- Score:
- 1
- Max. score:
- 1
- Reversibility:
- fully reversible within: 14 days
- Irritation parameter:
- conjunctivae score
- Remarks:
- redness
- Basis:
- animal #1
- Time point:
- 24/48/72 h
- Score:
- 2
- Max. score:
- 2
- Reversibility:
- fully reversible within: 21 days
- Irritation parameter:
- conjunctivae score
- Remarks:
- discharge
- Basis:
- animal #1
- Time point:
- 24/48/72 h
- Score:
- 3
- Max. score:
- 3
- Reversibility:
- fully reversible within: 21 days
- Irritation parameter:
- chemosis score
- Basis:
- animal #1
- Time point:
- 24/48/72 h
- Score:
- 3
- Max. score:
- 3
- Reversibility:
- fully reversible within: 14 days
- Irritation parameter:
- cornea opacity score
- Basis:
- animal #2
- Time point:
- 24/48/72 h
- Score:
- 0
- Max. score:
- 0
- Irritation parameter:
- iris score
- Basis:
- animal #2
- Time point:
- 24/48/72 h
- Score:
- 1
- Max. score:
- 1
- Reversibility:
- fully reversible within: 7 days
- Irritation parameter:
- conjunctivae score
- Remarks:
- redness
- Basis:
- animal #2
- Time point:
- 24/48/72 h
- Score:
- 2
- Max. score:
- 2
- Reversibility:
- fully reversible within: 14 days
- Irritation parameter:
- conjunctivae score
- Remarks:
- discharge
- Basis:
- animal #2
- Time point:
- 24/48/72 h
- Score:
- >= 1 - <= 2
- Max. score:
- 3
- Reversibility:
- fully reversible within: 7 days
- Irritation parameter:
- chemosis score
- Basis:
- animal #2
- Time point:
- 24/48/72 h
- Score:
- 2
- Max. score:
- 2
- Reversibility:
- fully reversible within: 14 days
- Other effects:
- Body weight gain within normal ranges
No othetr signs of toxicity or pain - Interpretation of results:
- Category 2 (irritating to eyes) based on GHS criteria
- Conclusions:
- The substance is irritating to the eyes
- Executive summary:
The substance was installed in the eye of 2 rabbits (subsequently treated). The results are indicative for the classification as irritating to the eyes (category 2).
- Endpoint:
- eye irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 12-03-2013 to 14-03-2013
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: not formally validated study method
- Principles of method if other than guideline:
- The SkinEthic reconstructed human corneal epithelium assay is used
- GLP compliance:
- yes (incl. QA statement)
- Details on study design:
- The SkinEthic reconstructed human corneal epithelium assay uses corneal epithelial tissue to assess penetration and concomittant cytotoxicity of the test substance.
In a pre-test direct interaction of the test substance with the detection chemical MTT is assessed. As the substance showed interference additional controls were added (freeze killed SkinEthic HCE tissues).
In the main study SkinEthic tissues were treated with 30 uL of the test substance during 10 minutes in triplicate. In addition a negative control (Na2HPO4 0.142 g/L; glucose 1.802 g/L; HEPES 7.149 g/L; KCl 0.224 g/L; NaCl 7.597 g/L) and a positive control (2% SDS) were included. After treatment tissues (2 per treatment) were rinsed and treated with MTT (incubation for 3 hours). Optical density of isopropanol extracted MTT solutions was measured at 540 nm. Viability was expressed as percentage MTT conversion versus negative control with a correction for true viability according to EpiSkin™ SOP, Version 1.8 (February 2009), ECVAM Skin Irritation Validation Study: Validation of the EpiSkin™ test method 15 min - 42 hours for the prediction of acute skin irritation of chemicals. ( TODTT = [ODTV – (ODkt - ODku)] )
Tissue viability ≥ 60% means non-irritant
Tissue viability < 60% means irritant
The third tissue per treatment was preserved for histopathology. - Irritation parameter:
- other: % viability
- Value:
- 57.2
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Other effects:
- The test substance interfered with the reduction of MTT to blue formazan salt (correction factor 0.252).
The validity criteria for the viability of positive control, < 60%, was met. - Interpretation of results:
- study cannot be used for classification
- Conclusions:
- The test substance is irritant in the SkinEthic reconstructed human corneal epithelium assay.
- Executive summary:
In this assay SkinEthic tissues were treated with 30 uL of the test substance in triplicate during 10 minutes. After treatment tissues (2 per treatment) were rinsed and treated with MTT. Optical density of extracted MTT solutions was measured at 540 nm. As the test substance interfered with MTT reduction to formazan, viability was expressed as percentage MTT conversion versus negative control with a correction for true viability (0.252). The true viability was 57.2%, which is indicative for irritant substances. As the assay is not formally validated, the results need to be regarded as preliminary, but worst case.
Referenceopen allclose all
Animal no |
1 |
2 |
|||||||||||
1 |
24 |
48 |
72 |
7 |
14 |
21 |
1 |
24 |
48 |
72 |
7 |
14 |
|
cornea |
1 |
1 |
1 |
1 |
1 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
iris |
1 |
1 |
1 |
1 |
1 |
0 |
0 |
1 |
1 |
1 |
1 |
0 |
0 |
conjunctivae |
|
|
|
|
|
|
|
|
|
|
|
|
|
redness |
2 |
2 |
2 |
2 |
2 |
1 |
0 |
2 |
2 |
2 |
2 |
1 |
0 |
chemosis |
3 |
3 |
3 |
3 |
1 |
0 |
0 |
2 |
2 |
2 |
2 |
1 |
0 |
discharge |
3 |
3 |
3 |
3 |
2 |
1 |
0 |
3 |
2 |
1 |
1 |
0 |
0 |
Mean OD540 |
Correction applied
|
Relative mean viability |
|
Negative control: |
0.976* |
|
100% |
Test substance: |
0.558* |
0.252# |
57.2% |
SDS: |
0.168* |
|
17.2% |
* TODTT = [ODTV – (ODkt - ODku)]
# correction value: ODkt - ODku
ODTV : chemical treated viable tissues
TODTT : true MTT metabolic conversion for treated tissue.
ODku : untreated killed tissues
ODkt: chemical treated killed tissues
No histopathology was performed.
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (irritating)
Respiratory irritation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
The substance is non-corrosive and non-irritant in the in vitro assays. As these assays are sufficiently validated, no further testing is considered necessary and the substance is considered non-irritant.
In the non-validated in vitro assay for eye irritation a slightly positive result was obtained. This result was confirmed by an in vivo test.
Justification for classification or non-classification
The available data on skin irritation of the test substance do not meet the criteria for classification according to Regulation (EC) 1272/2008, and are therefore conclusive but not sufficient for classification.
The available data on eye irritation of the test substance are indicative for eye irritation and , in a worst case approach, it is concluded that the substance meets the criteria for classification as H319 (causes serious eye irritation Category 2) according to Regulation (EC) 1272/2008 .
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.